News 2016
7 Tips To Help Avoid Costly Health Plan Enrollment Headaches
Consumers, many worried about rising premiums, shrinking provider networks and the departure of major insurers, enroll during the annual sign-up period which began November 1
With the annual sign-up period for plans on the health law's marketplaces underway, many consumers are worried about rising premiums, shrinking provider networks and the departure of major insurers such as UnitedHealthcare, Aetna and Humana from many exchanges.
Read more: 7 Tips To Help Avoid Costly Health Plan Enrollment Headaches
In This Issue
This week we continue our series of stories about the Heroes in the Struggle Hall of Fame inductees, with a story about SisterLove, Inc., founder/CEO Dázon Dixon Diallo. On World AIDS Day the Black AIDS Institute will recognize Dázon and several other honorees at the Heroes in the Struggle Gala and Award Celebration, a star-studded event and photographic tribute, taking place at the Director's Guild in Los Angeles. Go here for tickets or email
Heroes in the Struggle: Dázon Dixon Diallo
Dázon Dixon Diallo, Founder and CEO, SisterLove, Inc
The Black AIDS Institute's Heroes in the Struggle Gala and Award Celebration honors, in a star-studded event and photographic tribute, individuals who, over the past year, have made a heroic contribution to the fight against HIV/AIDS. Below, one in a series profiling the 2016 honorees.
AAHU Fellow Marxavian Jones: 'Nothing About Us Without Us'
Marxavian Jones (center) a 2016 AAHU graduate, he is flanked by Jeffrey Klausner, M.D. (left), Professor of Medicine, Division of Infectious Diseases and the Program in Global Health, UCLA; and Phill Wilson, Founder and C.E.O., Black AIDS Institute.
One in a series about recent graduates of the African American HIV University (AAHU).
Read more: AAHU Fellow Marxavian Jones: 'Nothing About Us Without Us'
ICYMI – Advances in Research on HIV Prevention for Women
Gina Brown, M.D., Director of Microbicides Research and Research on Women and Girls, Office of AIDS Research, National Institutes of Health
Last week, in a Facebook Live event we heard from NIH's Dr. Carl Dieffenbach about some new developments in HIV prevention for women shared at the HIV Research for Prevention Conference (R4P) in Chicago. Carl is the Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases. He and his colleague Anne Rancourt discussed some new findings from the ASPIRE study about the experiences of women who used a vaginal ring, which continuously releases the anti-HIV drug dapivirine.
Read more: ICYMI – Advances in Research on HIV Prevention for Women